NCT06611774

Brief Summary

Study the prevalence of metabolic syndrome in patients with knee osteoarthritis and conclude the relationship between metabolic syndrome and the severity of knee osteoarthritis

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
174

participants targeted

Target at P50-P75 for all trials

Timeline
9mo left

Started Oct 2024

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Oct 2024Feb 2027

First Submitted

Initial submission to the registry

August 9, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 25, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

September 25, 2024

Status Verified

September 1, 2024

Enrollment Period

2.1 years

First QC Date

August 9, 2024

Last Update Submit

September 22, 2024

Conditions

Keywords

knee osteoarthritismetabolic syndrome

Outcome Measures

Primary Outcomes (1)

  • Metabolic syndrome in patients with knee osteoarthritis

    Study the prevalence of metabolic syndrome in patients with knee osteoarthritis and the relation between metabolic syndrome and clinical, functional, radiological finding of knee osteoarthritis

    Baseline

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted in assiut university hospitals and presenting to its clinics

You may qualify if:

  • Both males and female .
  • Age between 30 and 70 years old.
  • Patient fulfill the criteria of knee osteoarthritis .

You may not qualify if:

  • Patients known to have rheumatological disease .
  • Patients with meniscal or cruciate ligament injury .
  • Patients with previous knee surgery .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • Maddah S, Mahdizadeh J. Association of Metabolic Syndrome and Its Components with Knee Osteoarthritis. Acta Med Iran. 2015 Dec;53(12):743-8.

    PMID: 26749230BACKGROUND
  • Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010 Aug;26(3):355-69. doi: 10.1016/j.cger.2010.03.001.

    PMID: 20699159BACKGROUND
  • Goldring SR, Goldring MB. Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk. Nat Rev Rheumatol. 2016 Nov;12(11):632-644. doi: 10.1038/nrrheum.2016.148. Epub 2016 Sep 22.

    PMID: 27652499BACKGROUND
  • Xie DX, Wei J, Zeng C, Yang T, Li H, Wang YL, Long HZ, Wu ZY, Qian YX, Li KH, Lei GH. Association between metabolic syndrome and knee osteoarthritis: a cross-sectional study. BMC Musculoskelet Disord. 2017 Dec 16;18(1):533. doi: 10.1186/s12891-017-1890-9.

    PMID: 29246142BACKGROUND
  • Courties A, Sellam J. Osteoarthritis and type 2 diabetes mellitus: What are the links? Diabetes Res Clin Pract. 2016 Dec;122:198-206. doi: 10.1016/j.diabres.2016.10.021. Epub 2016 Nov 5.

    PMID: 27889689BACKGROUND
  • Tu C, He J, Wu B, Wang W, Li Z. An extensive review regarding the adipokines in the pathogenesis and progression of osteoarthritis. Cytokine. 2019 Jan;113:1-12. doi: 10.1016/j.cyto.2018.06.019. Epub 2018 Jun 28.

    PMID: 30539776BACKGROUND

MeSH Terms

Conditions

Osteoarthritis, KneeMetabolic Syndrome

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Central Study Contacts

Fady Kerollos Louis, Dr

CONTACT

Salwa Salaheldin Elgendi, professor

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

August 9, 2024

First Posted

September 25, 2024

Study Start

October 1, 2024

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

February 1, 2027

Last Updated

September 25, 2024

Record last verified: 2024-09